These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38189813)
1. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer. Fang Y; Zhang Q; Chen Z; Guo C; Wu J Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813 [TBL] [Abstract][Full Text] [Related]
2. Identification and comprehensive analysis of epithelial-mesenchymal transition related target genes of miR-222-3p in breast cancer. Fang Y; Zhang Q; Chen C; Chen Z; Zheng R; She C; Zhang R; Wu J Front Oncol; 2023; 13():1189635. PubMed ID: 37546414 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2. He J; Wang J; Li S; Li T; Chen K; Zhang S Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486 [TBL] [Abstract][Full Text] [Related]
4. Deregulation of miR-1245b-5p and miR-92a-3p and their potential target gene, GATA3, in epithelial-mesenchymal transition pathway in breast cancer. Yadollahi Farsani M; Amini Farsani Z; Teimuri S; Kolahdouzan M; Eshraghi Samani R; Teimori H Cancer Rep (Hoboken); 2024 Feb; 7(2):e1955. PubMed ID: 38173189 [TBL] [Abstract][Full Text] [Related]
5. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2. Wang H; Hu X; Yang F; Xiao H Oncol Res; 2021 Sep; 28(7):731-744. PubMed ID: 33419488 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659 [TBL] [Abstract][Full Text] [Related]
8. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway. Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950 [TBL] [Abstract][Full Text] [Related]
9. The effect of low molecular weight-polycyclic aromatic hydrocarbons responsive hsa_circ_0039929/hsa-miR-15b-3p_R-1/FGF2 circuit on inflammatory response of A549 cells via the PI3K/AKT pathway and epithelial-mesenchymal transition process. Huang Y; Huang Y; Wang H; Zhang H; Shi L; Li C; Li X; Zeng Y; Liu Y; Wu M; Wang J; Wang J Environ Toxicol; 2022 Aug; 37(8):2005-2018. PubMed ID: 35475590 [TBL] [Abstract][Full Text] [Related]
10. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971 [TBL] [Abstract][Full Text] [Related]
11. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin. Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression. Zhang L; Yan R; Zhang SN; Zhang HZ; Ruan XJ; Cao Z; Gu XZ Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1986-1995. PubMed ID: 30915741 [TBL] [Abstract][Full Text] [Related]
13. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer. Li X; Zhu J; Liu Y; Duan C; Chang R; Zhang C Cancer Sci; 2019 Jun; 110(6):1883-1896. PubMed ID: 30955235 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer. Sun G; Liu M; Han H J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707 [TBL] [Abstract][Full Text] [Related]
16. Circular RNA hsa_circ_0053277 promotes the development of colorectal cancer by upregulating matrix metallopeptidase 14 via miR-2467-3p sequestration. Xiao H; Liu M J Cell Physiol; 2020 Mar; 235(3):2881-2890. PubMed ID: 31549406 [TBL] [Abstract][Full Text] [Related]
17. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling. Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753 [TBL] [Abstract][Full Text] [Related]
19. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY; Men CJ; Ding XW J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]